213 related articles for article (PubMed ID: 7783568)
1. P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation.
Shustik C; Dalton W; Gros P
Mol Aspects Med; 1995; 16(1):1-78. PubMed ID: 7783568
[No Abstract] [Full Text] [Related]
2. The role of P-glycoprotein in drug resistance in multiple myeloma.
Abraham J; Salama NN; Azab AK
Leuk Lymphoma; 2015 Jan; 56(1):26-33. PubMed ID: 24678978
[TBL] [Abstract][Full Text] [Related]
3. Using purified P-glycoprotein to understand multidrug resistance.
Shapiro AB; Ling V
J Bioenerg Biomembr; 1995 Feb; 27(1):7-13. PubMed ID: 7629053
[TBL] [Abstract][Full Text] [Related]
4. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of multidrug resistance in acute leukemia.
Dutcher JP; Wiernik PH
Leuk Res; 2002 Mar; 26(3):323-5. PubMed ID: 11792423
[No Abstract] [Full Text] [Related]
6. Multidrug resistance: clinical relevance in haematological malignancies.
Kaye SB; Kerr DJ
Blood Rev; 1991 Mar; 5(1):38-41. PubMed ID: 1674435
[TBL] [Abstract][Full Text] [Related]
7. Modulation of multidrug resistance in multiple myeloma.
Sonneveld P
Baillieres Clin Haematol; 1995 Dec; 8(4):831-44. PubMed ID: 8845575
[TBL] [Abstract][Full Text] [Related]
8. Characterization and functional reconstitution of the multidrug transporter.
Sharom FJ
J Bioenerg Biomembr; 1995 Feb; 27(1):15-22. PubMed ID: 7629046
[TBL] [Abstract][Full Text] [Related]
9. The P-glycoprotein multidrug transporter: interactions with membrane lipids, and their modulation of activity.
Sharom FJ
Biochem Soc Trans; 1997 Aug; 25(3):1088-96. PubMed ID: 9388605
[No Abstract] [Full Text] [Related]
10. In vitro models of multiple drug resistance.
Greenberger LM; Cohen D; Horwitz SB
Cancer Treat Res; 1994; 73():69-106. PubMed ID: 7710911
[No Abstract] [Full Text] [Related]
11. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.
Di Pietro A; Dayan G; Conseil G; Steinfels E; Krell T; Trompier D; Baubichon-Cortay H; Jault J
Braz J Med Biol Res; 1999 Aug; 32(8):925-39. PubMed ID: 10454753
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of P-glycoprotein expression in haematological malignancies.
Nooter K; Sonneveld P
Leuk Res; 1994 Apr; 18(4):233-43. PubMed ID: 7909572
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance--a fascinating, clinically relevant problem in bioenergetics.
Pedersen PL
J Bioenerg Biomembr; 1995 Feb; 27(1):3-5. PubMed ID: 7629048
[No Abstract] [Full Text] [Related]
14. The role of P-glycoprotein in drug-resistant hematologic malignancies.
Dalton WS; Grogan TM; Miller TP
Cancer Treat Res; 1991; 57():187-208. PubMed ID: 1686717
[No Abstract] [Full Text] [Related]
15. Clinical reversal of multidrug resistance.
Sikic BI; Fisher GA; Lum BL; Brophy NA; Yahanda AM; Adler KM; Halsey J
Cancer Treat Res; 1994; 73():149-65. PubMed ID: 7710904
[No Abstract] [Full Text] [Related]
16. Multidrug resistance: genes, polymorphisms, biologic effects, reversal and treatment in cancer chemotherapy.
Aragon-Ching JB
Anticancer Agents Med Chem; 2010 Oct; 10(8):582. PubMed ID: 21244347
[No Abstract] [Full Text] [Related]
17. Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.
Germann UA; Shlyakhter D; Mason VS; Zelle RE; Duffy JP; Galullo V; Armistead DM; Saunders JO; Boger J; Harding MW
Anticancer Drugs; 1997 Feb; 8(2):125-40. PubMed ID: 9073309
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein--a mediator of multidrug resistance in tumour cells.
Germann UA
Eur J Cancer; 1996 Jun; 32A(6):927-44. PubMed ID: 8763334
[No Abstract] [Full Text] [Related]
19. New light on multidrug binding by an ATP-binding-cassette transporter.
Shilling RA; Venter H; Velamakanni S; Bapna A; Woebking B; Shahi S; van Veen HW
Trends Pharmacol Sci; 2006 Apr; 27(4):195-203. PubMed ID: 16545467
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance (MDR) genes in haematological malignancies.
Nooter K; Sonneveld P
Cytotechnology; 1993; 12(1-3):213-30. PubMed ID: 7765326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]